UTERINE LEIOMYOSARCOMA

UTERINE LEIOMYOSARCOMA was reported 80 times

UTERINE LEIOMYOSARCOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Microtubule Inhibitor [EPC] 10 0.0001
1 Orexin Receptor Antagonist [EPC] 1 0.0001
2 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
3 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
4 Complement Inhibitor [EPC] 2 0.0000
5 Alkylating Drug [EPC] 6 0.0000
6 Interferon beta [EPC] 3 0.0000
7 HER2/neu Receptor Antagonist [EPC] 1 0.0000
8 Integrin Receptor Antagonist [EPC] 1 0.0000
9 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
10 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
11 Progestin [EPC] 3 0.0000
12 Aminosalicylate [EPC] 1 0.0000
13 Interleukin-12 Antagonist [EPC] 1 0.0000
14 Interleukin-23 Antagonist [EPC] 1 0.0000
15 Antirheumatic Agent [EPC] 1 0.0000
16 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
17 Aromatase Inhibitor [EPC] 1 0.0000
18 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
19 Kinase Inhibitor [EPC] 4 0.0000
20 Azole Antifungal [EPC] 1 0.0000
21 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
22 RANK Ligand Inhibitor [EPC] 1 0.0000
23 Vitamin C [EPC] 2 0.0000
24 Opioid Agonist [EPC] 1 0.0000
25 Platinum-based Drug [EPC] 1 0.0000
26 Factor Xa Inhibitor [EPC] 1 0.0000
27 Vitamin D [EPC] 1 0.0000
28 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
29 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
30 Vitamin B12 [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
32 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
33 Atypical Antipsychotic [EPC] 1 0.0000
34 Thalidomide Analog [EPC] 1 0.0000
35 Platelet Aggregation Inhibitor [EPC] 1 0.0000
36 Proton Pump Inhibitor [EPC] 1 0.0000
37 Corticosteroid [EPC] 2 0.0000
38 Tumor Necrosis Factor Blocker [EPC] 1 0.0000